Skip to Content
Merck
  • Monitoring and Targeting Anti-VEGF Induced Hypoxia within the Viable Tumor by

Monitoring and Targeting Anti-VEGF Induced Hypoxia within the Viable Tumor by

Neoplasia (New York, N.Y.) (2017-10-11)
Yunzhou Shi, Jason Oeh, Anna Hitz, Maj Hedehus, Jeffrey Eastham-Anderson, Franklin V Peale, Patricia Hamilton, Thomas O'Brien, Deepak Sampath, Richard A D Carano
ABSTRACT

The effect of anti-angiogenic agents on tumor oxygenation has been in question for a number of years, where both increases and decreases in tumor pO

MATERIALS
Product Number
Brand
Product Description

Sigma-Aldrich
Tirapazamine, ≥98% (HPLC)